Stenocare A/S (CPH:STENO)
Denmark · Delayed Price · Currency is DKK 1.215
-0.070 (-5.45%)
May 8, 2026, 4:51 PM CET
Stenocare Revenue
In the year 2025, Stenocare had annual revenue of 7.02M DKK with 214.56% growth. Stenocare had revenue of 2.61M in the quarter ending December 31, 2025, with 107.12% growth.
Revenue
7.02M
Revenue Growth
+214.56%
P/S Ratio
5.68
Revenue / Employee
2.31M
Employees
4
Market Cap
52.48M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.02M | 4.79M | 214.56% |
| Dec 31, 2024 | 2.23M | -1.53M | -40.61% |
| Dec 31, 2023 | 3.76M | -731.58K | -16.30% |
| Dec 31, 2022 | 4.49M | 2.60M | 137.54% |
| Dec 31, 2021 | 1.89M | 1.69M | 852.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 309.06B |
| Coloplast | 27.89B |
| Genmab | 23.66B |
| ALK-Abelló | 6.56B |
| ChemoMetec | 493.12M |
| Scandinavian Medical Solutions | 245.44M |
| BioPorto | 40.29M |
| Monsenso | 8.91M |
Stenocare News
- 1 year ago - Stenocare Earnings Call Transcript: Q3 2024 - Transcripts
- 2 years ago - Stenocare Transcript: Investor Update - Transcripts
- 2 years ago - Stenocare Earnings Call Transcript: Q1 2024 - Transcripts